Biotechnology Virtual FDA Advisory Committee Meeting to Review New Drug Application for ALKS 3831 for Treatment of Schizophrenia and Bipolar I Disorder Tentatively Scheduled for Oct. 9, 2020 August 21, 2020
Biotechnology Pfizer and BioNTech Share Positive Early Data on Lead mRNA Vaccine Candidate BNT162b2 Against COVID-19 August 20, 2020
Biotechnology (IMMU) Alert: Shareholder Class Action Against Immunomedics Survives Motion to Dismiss; Should Management be Held Accountable for Investors Losses? Contact Johnson Fistel August 20, 2020
Biotechnology Axsome Therapeutics Completes Successful FDA Pre-NDA Meeting for AXS-07 for the Acute Treatment of Migraine August 20, 2020
Energy Should First Trust Mid Cap Growth AlphaDEX ETF (FNY) Be on Your Investing Radar? August 20, 2020